Altered cortical visual processing in PD with hallucinations: an fMRI study

Neurology. 2004 Oct 26;63(8):1409-16. doi: 10.1212/01.wnl.0000141853.27081.bd.

Abstract

Objective: To compare fMRI activation during two visual stimulation paradigms in Parkinson disease (PD) subjects with chronic visual hallucinations vs PD patients who had never hallucinated.

Methods: Twelve pairs of PD subjects, matched for age, PD duration, and dopaminergic drug exposure duration, participated in this study. The authors examined group differences in activation during stroboscopic (flashing) vs no visual stimulation and kinematic (apparent motion) vs stationary visual stimulation.

Results: During stroboscopic stimulation, non-hallucinating PD subjects showed significantly greater activation in the parietal lobe and cingulate gyrus compared to hallucinating PD subjects. In contrast, the hallucinating subjects showed significantly greater activation in the inferior frontal gyrus and the caudate nucleus. During kinematic stimulation, non-hallucinating PD subjects showed significantly greater activation in area V5/MT, parietal lobe, and cingulate gyrus compared to hallucinating PD subjects. Hallucinating PD subjects showed significantly greater activation in the superior frontal gyrus.

Conclusions: PD patients with chronic visual hallucinations respond to visual stimuli with greater frontal and subcortical activation and less visual cortical activation than non-hallucinating PD subjects. Shifting visual circuitry from posterior to anterior regions associated primarily with attention processes suggests altered network organization may play a role in the pathophysiology of visual hallucinations in PD.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Attention / physiology
  • Case-Control Studies
  • Caudate Nucleus / pathology
  • Caudate Nucleus / physiopathology
  • Cerebral Cortex / pathology
  • Cerebral Cortex / physiopathology*
  • Chronic Disease
  • Cohort Studies
  • Dopamine Agents / therapeutic use
  • Frontal Lobe / pathology
  • Frontal Lobe / physiopathology
  • Gyrus Cinguli / pathology
  • Gyrus Cinguli / physiopathology
  • Hallucinations / diagnosis*
  • Hallucinations / etiology
  • Hallucinations / physiopathology*
  • Humans
  • Magnetic Resonance Imaging
  • Parietal Lobe / pathology
  • Parietal Lobe / physiopathology
  • Parkinson Disease / complications*
  • Photic Stimulation
  • Visual Pathways / pathology
  • Visual Pathways / physiopathology*
  • Visual Perception / physiology*

Substances

  • Dopamine Agents